Illumina, every mention
10 scenes, the whole family · ← back to Illumina
tap a year for its mentions
every year anyone Malinka Walaliyadde 10Jorge Conde 6Elliot Hershberg 2Balaji Srinivasan 2Gabriel Ott 1
Verbatim, from the transcripts: the passages where Illumina comes up
The Brutal Truth About Biotech: Why $2B Per Drug Is Killing Innovation
- ▶ 59:28 Elliot Hershberg So at one point Illumina sold exactly zero dot zero dollars of next generation sequencing technology to the industry, right? 2 times in the scene
Steven Sinofsky & Balaji Srinivasan on the Future of M&A, AI & Tech
- ▶ 32:24 Balaji Srinivasan Where it was about 10 exercises and it worked, and that was, uh, Illumina's acquisition of Celexa, where it was like a must win, that's in the genome sequencing space, but that, or genome sequencing space, that's where, uh, there was like… 2 times in the scene
a16z Podcast | When (and How) Biology Becomes Engineering
- ▶ 21:16 Jorge Conde But it's what Illumina did for sequencing, right?
a16z Podcast | Taking the Pulse on Bio
- ▶ 8:47 Jorge Conde What drove that was Illumina was able to apply
a16z Podcast | On the Genomics of Disease, From Science to Business
- ▶ 4:15 Malinka Walaliyadde The dominant player in the sequencing machine space has almost entirely by itself been driving down the cost of sequencing over the last decade or so. 2 times in the scene
- ▶ 5:49 Gabriel Ott So some of the things that you can do in computational biology, for example, is take the DNA data that's coming from an Illumina sequencer, for example, tremendous amounts of data.
- ▶ 16:25 Malinka Walaliyadde You know, the major news in the genomic industry this week, which is the largest genomics company of any kind at the sequencing layer, about two days ago had a 25% drop in their market cap, which definitely send waves in the industry. 8 times in the scene
Shifting Risk Mindsets, from Tech to Bio
- ▶ 20:10 Jorge Conde I don't know what a box, a magic box that could make engineer bacteria would look like, but let's assume that this is something you could productize as an instrument, kind of like what Illumina has done, where you sort of now go into this…
Pande & Conde: When (and How) Biology Becomes Engineering
- ▶ 20:52 Jorge Conde But it's what Illumina did for sequencing.
Challenges in Healthcare Innovation
- ▶ 15:59 Jorge Conde And perhaps the most illustrative example of the potential of these kinds of companies is Illumina. 2 times in the scene